Citadel Advisors »

Beam Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.6M 395k 24.27
2025-06-30 $47M 2.8M 17.01
2025-03-31 $53M 2.7M 19.53
2024-12-31 $54M 2.2M 24.80
2024-09-30 $40M 1.6M 24.50
2024-06-30 $22M 938k 23.43
2024-03-31 $6.5M 196k 33.04
2023-12-31 $3.3M 120k 27.22
2023-09-30 $34M 1.4M 24.05
2023-06-30 $13M 406k 31.93
2023-03-31 $12M 385k 30.62
2022-12-31 $14M 366k 39.11
2022-06-30 $8.7M 225k 38.70
2022-03-31 $21M 358k 57.30
2021-12-31 $18M 220k 79.69
2021-09-30 $32M 363k 87.01
2021-06-30 $18M 141k 128.71
2021-03-31 $23M 286k 80.04
2020-12-31 $8.5M 105k 81.64
2020-06-30 $757k 27k 27.91
2020-03-31 $1.6M 86k 18.00